Clinical correlation between brain natriutetic peptide and anthracyclin-induced cardiac toxicity
about
The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer TherapyUse of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculographySerum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity.Role of biomarkers in cardioncology.Using cardiac biomarkers and treating cardiotoxicity in cancer.Cardiotoxicity due to Chemotherapy: the Role of Biomarkers.Cardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts.Alternative Biomarkers for Combined Biology.Mitogen-activated protein kinases pathways mediate the sunitinib-induced hypertrophy in rat cardiomyocyte H9c2 cells.Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy.Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.Exaggerated NT-proBNP production in patients with hematologic malignancies: a case series.Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: a single center experience.Cardiac complications of chemotherapy: role of biomarkers.Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress.
P2860
Q26743433-E8B03185-3F6D-4411-9EDE-C986FF177AAEQ27027354-3E19C750-5EB9-46FB-93C4-345FF63C0EAFQ28538548-8BBE3463-A4E3-48FB-ABC1-796729D653B5Q36825438-11B4647B-6E0D-4D83-B374-2FA934E4C6C7Q37926595-4654B2D5-9A99-40B8-A571-91B76DCB54C3Q38069202-BCEBE9A0-F3EB-43D9-9FE6-0EB7CF82D668Q38508938-6B5D7658-50C8-4106-9F31-025567445BB9Q38657849-25A14FE1-7A03-456D-BB23-AAD5B211F493Q38747992-BC74987B-C996-4120-90DC-ADE1392724B6Q38979036-B0AD20B1-495B-4BCD-ABC7-9C0133D8BB69Q39018351-D5CFEBB7-88FE-4D2B-80F6-412A39BF3248Q45073135-28C5D310-821B-49FA-89E6-6C2EB468C8A3Q45192225-410E3C6B-7873-4609-9157-DA965FA6D22FQ48461764-04272E07-5484-4C26-80B0-4CDAC1FAACF5Q51739297-04A8970E-0213-432D-92BD-FA5D4F217EB2Q53230021-D6B3FA5D-8FE5-4F83-B4E0-F108DD72E0FF
P2860
Clinical correlation between brain natriutetic peptide and anthracyclin-induced cardiac toxicity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical correlation between b ...... yclin-induced cardiac toxicity
@en
Clinical correlation between b ...... clin-induced cardiac toxicity.
@nl
type
label
Clinical correlation between b ...... yclin-induced cardiac toxicity
@en
Clinical correlation between b ...... clin-induced cardiac toxicity.
@nl
prefLabel
Clinical correlation between b ...... yclin-induced cardiac toxicity
@en
Clinical correlation between b ...... clin-induced cardiac toxicity.
@nl
P2093
P2860
P1476
Clinical correlation between b ...... yclin-induced cardiac toxicity
@en
P2093
Chang Bae Son
Ho Sup Lee
Seong Hoon Shin
Yang Soo Kim
P2860
P304
P356
10.4143/CRT.2008.40.3.121
P577
2008-09-30T00:00:00Z